期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 53, 期 3, 页码 285-305出版社
ELSEVIER
DOI: 10.1016/S0169-409X(01)00233-2
关键词
Liposomes; hyperthermia; doxorubicin; FaDu tumors; lysolipid
资金
- NCI NIH HHS [CA 40355, CA 87630, CA 42745] Funding Source: Medline
- NIGMS NIH HHS [GM 40162] Funding Source: Medline
Our laboratories have been working together in close collaboration for over 10 years concerning the design and performance of lipid-based drug delivery systems. Over the past 3 years we have conceived of, developed, and tested pre-clinically, a new liposome-based temperature-sensitive drug delivery system for the treatment of solid tumors. This work is reported in a series of four publications: 'J. Liposome Res. 9 (1999) 491; Cancer Res. Adv. Brief 60(5) (2000) 1197; Cancer Res. 6(9) (2000) 748; and Cancer Res. 60 (2000) 6950'. Following a brief introduction concerning the motivations behind the work, this article will review these studies, including some of our earlier work that led to these ideas, and will present the rational design of the new liposome formulation from a materials engineering perspective. (C) 2001 Published by Elsevier Science B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据